Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Vertex Pharmaceuticals Incorporated | StockGist | StockGist

Companies
VRTX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings VRTXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Vertex Pharmaceuticals Incorporated

Filed Feb 12, 2025

Accepted Feb 11, 2025, 7:00 PM ET

CIK 0000875320

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

VERTEX PHARMACEUTICALS INC / MA

Person Type

HC

CUSIP: 92532F100

Amendment History

5 filings

SCHEDULE 13G
Original
May 13, 20250001422848-25-000080
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 12, 20250000315066-25-000927
SCHEDULE 13G/A
Amendment 2
Feb 13, 20250001422849-25-000012
SCHEDULE 13G/A
Amendment 3
Feb 12, 20260001422848-26-000023
SCHEDULE 13G/A
Amendment 4
Latest
Mar 27, 20260000102909-26-002578

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

Vertex Pharmaceuticals Incorporated5 days ago

Vertex Pharmaceuticals Incorporated1 weeks ago

Vertex Pharmaceuticals Incorporated1 months ago

Vertex Pharmaceuticals Incorporated1 months ago

Vertex Pharmaceuticals Incorporated1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice